Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Are pre-menopausal females, and who are healthy as determined by medical history and physical examination
Have a body mass index of 18 to 30 kilograms per square meter (kg/m\^2)
You may not be if
Have known allergies to evacetrapib and Ortho-Cyclen (ethinyl estradiol and norgestimate), related compounds or any components of the formulation
Have a clinically significant abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, increases the risks associated with participating in the study
Regularly use known drugs of abuse and/or show positive findings on urinary drug screening
Have taken injectable contraceptives within 12 months prior to the first dose of the lead-in period or topical controlled delivery contraceptives (patch) for 3 months prior to the first dose of the lead-in period
Use of any tobacco- or nicotine-containing products within 6 months prior to the lead-in phase and during the study
